|Articles|January 18, 2002

CDER News 12/31/01 through 1/2/02

Original manufacturing supplements, original efficacy supplements, original and resubmitted NDAs, and new and generic drug approvals.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content